(PHIN) PHINIA - Overview
Stock: Fuel Systems, Injectors, Injectors, Alternators, Remanufactured Parts
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.14% |
| Yield on Cost 5y | 3.97% |
| Yield CAGR 5y | 46.97% |
| Payout Consistency | 100.0% |
| Payout Ratio | 28.4% |
| Risk 5d forecast | |
|---|---|
| Volatility | 31.8% |
| Relative Tail Risk | -7.43% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.24 |
| Alpha | 30.26 |
| Character TTM | |
|---|---|
| Beta | 1.039 |
| Beta Downside | 1.449 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.71% |
| CAGR/Max DD | 0.97 |
Description: PHIN PHINIA January 14, 2026
PHINIA Inc. (NYSE:PHIN) designs, develops and manufactures integrated automotive components, operating through two primary segments: Fuel Systems and Aftermarket. The Fuel Systems segment supplies advanced fuel injection hardware-including pumps, injectors, rail assemblies, and electronic control modules-plus software and calibration services aimed at lowering emissions and improving fuel economy for both conventional and hybrid powertrains. The Aftermarket segment sells starters, alternators, remanufactured units, test equipment and diagnostic solutions to OEMs and service providers across a broad vehicle spectrum, from heavy-duty trucks and buses to light-commercial vans and passenger cars.
Key industry data that may affect PHIN’s outlook: (1) Global fuel-injection market revenue is projected to reach ≈ $30 billion by 2027, growing at a 5-6% CAGR, driven by stricter emissions regulations and the shift to hybrid powertrains; (2) Aftermarket parts sales in North America have risen ≈ 3% YoY in 2024, buoyed by fleet replacement cycles and extended vehicle lifespans; (3) The U.S. commercial-vehicle fleet is expected to expand ≈ 2% annually through 2028, supporting demand for PHIN’s medium- and heavy-duty offerings. These trends suggest a modest secular tailwind, but PHIN’s recent 2023 incorporation means limited historical financials, increasing valuation uncertainty.
For a deeper, data-driven look at PHIN’s valuation assumptions and cash-flow profile, the ValueRay platform provides a granular, up-to-date analysis worth reviewing.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 90.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 1.65 > 1.0 |
| NWC/Revenue: 23.34% < 20% (prev 27.64%; Δ -4.29% < -1%) |
| CFO/TA 0.07 > 3% & CFO 289.0m > Net Income 90.0m |
| Net Debt (697.0m) to EBITDA (399.0m): 1.75 < 3 |
| Current Ratio: 1.72 > 1.5 & < 3 |
| Outstanding Shares: last quarter (39.6m) vs 12m ago -10.20% < -2% |
| Gross Margin: 21.51% > 18% (prev 0.22%; Δ 2129 % > 0.5%) |
| Asset Turnover: 85.56% > 50% (prev 85.79%; Δ -0.23% > 0%) |
| Interest Coverage Ratio: 3.37 > 6 (EBITDA TTM 399.0m / Interest Expense TTM 78.0m) |
Altman Z'' 1.84
| A: 0.20 (Total Current Assets 1.92b - Total Current Liabilities 1.12b) / Total Assets 3.99b |
| B: 0.02 (Retained Earnings 97.0m / Total Assets 3.99b) |
| C: 0.07 (EBIT TTM 263.0m / Avg Total Assets 4.01b) |
| D: 0.00 (Book Value of Equity 8.00m / Total Liabilities 2.40b) |
| Altman-Z'' Score: 1.84 = BBB |
Beneish M -3.03
| DSRI: 0.98 (Receivables 898.0m/921.0m, Revenue 3.43b/3.45b) |
| GMI: 1.01 (GM 21.51% / 21.67%) |
| AQI: 1.09 (AQ_t 0.30 / AQ_t-1 0.28) |
| SGI: 0.99 (Revenue 3.43b / 3.45b) |
| TATA: -0.05 (NI 90.0m - CFO 289.0m) / TA 3.99b) |
| Beneish M-Score: -3.03 (Cap -4..+1) = AA |
What is the price of PHIN shares?
Over the past week, the price has changed by +3.54%, over one month by +9.53%, over three months by +40.43% and over the past year by +49.52%.
Is PHIN a buy, sell or hold?
- StrongBuy: 2
- Buy: 0
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PHIN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 78 | 5.8% |
| Analysts Target Price | 78 | 5.8% |
| ValueRay Target Price | 91 | 23.4% |
PHIN Fundamental Data Overview February 03, 2026
P/E Forward = 12.5
P/S = 0.8079
P/B = 1.7074
Revenue TTM = 3.43b USD
EBIT TTM = 263.0m USD
EBITDA TTM = 399.0m USD
Long Term Debt = 966.0m USD (from longTermDebt, last quarter)
Short Term Debt = 45.0m USD (from shortTermDebt, last quarter)
Debt = 1.05b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 697.0m USD (from netDebt column, last quarter)
Enterprise Value = 3.47b USD (2.77b + Debt 1.05b - CCE 349.0m)
Interest Coverage Ratio = 3.37 (Ebit TTM 263.0m / Interest Expense TTM 78.0m)
EV/FCF = 14.26x (Enterprise Value 3.47b / FCF TTM 243.0m)
FCF Yield = 7.01% (FCF TTM 243.0m / Enterprise Value 3.47b)
FCF Margin = 7.09% (FCF TTM 243.0m / Revenue TTM 3.43b)
Net Margin = 2.63% (Net Income TTM 90.0m / Revenue TTM 3.43b)
Gross Margin = 21.51% ((Revenue TTM 3.43b - Cost of Revenue TTM 2.69b) / Revenue TTM)
Gross Margin QoQ = 22.03% (prev 21.35%)
Tobins Q-Ratio = 0.87 (Enterprise Value 3.47b / Total Assets 3.99b)
Interest Expense / Debt = 1.91% (Interest Expense 20.0m / Debt 1.05b)
Taxrate = 31.58% (6.00m / 19.0m)
NOPAT = 179.9m (EBIT 263.0m * (1 - 31.58%))
Current Ratio = 1.72 (Total Current Assets 1.92b / Total Current Liabilities 1.12b)
Debt / Equity = 0.66 (Debt 1.05b / totalStockholderEquity, last quarter 1.59b)
Debt / EBITDA = 1.75 (Net Debt 697.0m / EBITDA 399.0m)
Debt / FCF = 2.87 (Net Debt 697.0m / FCF TTM 243.0m)
Total Stockholder Equity = 1.58b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.25% (Net Income 90.0m / Total Assets 3.99b)
RoE = 5.69% (Net Income TTM 90.0m / Total Stockholder Equity 1.58b)
RoCE = 10.33% (EBIT 263.0m / Capital Employed (Equity 1.58b + L.T.Debt 966.0m))
RoIC = 7.00% (NOPAT 179.9m / Invested Capital 2.57b)
WACC = 7.43% (E(2.77b)/V(3.81b) * Re(9.74%) + D(1.05b)/V(3.81b) * Rd(1.91%) * (1-Tc(0.32)))
Discount Rate = 9.74% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -8.21%
[DCF Debug] Terminal Value 82.89% ; FCFF base≈217.4m ; Y1≈262.8m ; Y5≈427.3m
Fair Price DCF = 194.8 (EV 8.19b - Net Debt 697.0m = Equity 7.49b / Shares 38.4m; r=7.43% [WACC]; 5y FCF grow 22.33% → 2.90% )
EPS Correlation: -10.91 | EPS CAGR: -64.86% | SUE: -4.0 | # QB: 0
Revenue Correlation: 26.62 | Revenue CAGR: 2.18% | SUE: 0.09 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.15 | Chg30d=-0.001 | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=5.84 | Chg30d=+0.151 | Revisions Net=+0 | Growth EPS=+17.9% | Growth Revenue=+2.4%